Abstract:Taï Forest virus (TAFV) is a negative-sense RNA virus in the Filoviridae family. TAFV has caused only a single human infection, but several disease outbreaks in chimpanzees have been linked to this virus. Limited research has been done on this human-pathogenic virus. We sought to establish an animal model to assess TAFV disease progression and pathogenicity at our facility. We had access to two different viral stock preparations from different institutions, both originating from the single human case. Type I interferon receptor knockout mice were inoculated with TAFV stock 1 or stock 2 by the intraperitoneal route. Inoculation resulted in 100% survival with no disease regardless of viral stock preparation or infectious dose. Next, cynomolgus macaques were inoculated with TAFV stock 1 or stock 2. Inoculation with TAFV stock 1 resulted in 100% survival and robust TAFV glycoprotein-specific IgG responses including neutralizing antibodies. In contrast, macaques infected with TAFV stock 2 developed disease and were euthanized 8–11 days after infection exhibiting viremia, thrombocytopenia, and increased inflammatory mediators identified by transcriptional analysis. Histopathologic analysis of tissue samples collected at necropsy confirmed classic filovirus disease in numerous organs. Genomic differences in both stock preparations were mapped to several viral genes which may have contributed to disease severity. Taken together, we demonstrate that infection with the two TAFV stocks resulted in no disease in mice and opposing disease phenotypes in cynomolgus macaques, highlighting the impact of viral stock propagation on pathogenicity in animal models. The 2014–2016 West Africa Ebola virus epidemic was the largest in history affecting 10 countries globally, highlighting concerns for future filovirus outbreaks. In contrast, Taï Forest virus (TAFV), another filovirus, has caused a single human case of infection originating from a TAFV disease outbreak in chimpanzees in West Africa which demonstrates transmission to humans. However, limited research has been performed on this human pathogen. We wanted to fill this knowledge gap and characterize disease as more filovirus outbreaks occur in West Africa. We had access to two TAFV stock preparations with sequence differences from separate institutions, both originating from the single human case. The impact of sequence differences on TAFV pathogenicity was assessed cohorts of mice and macaques by infection with either TAFV stock. While both stocks caused no disease in mice, macaques displayed opposing disease phenotypes. Infection with TAFV stock 1 resulted in 100% survival with minimal disease; in contrast, macaques infected with TAFV stock 2 developed fatal disease within 11 days. Genomic differences between stock preparations were associated with viral entry and genome replication which could contribute to disease severity. This study highlights the importance of viral genomic differences and their impact on viral pathogenicity.

Pathogenic differences of cynomolgus macaques after Taï Forest virus infection depend on the viral stock propagation

Exposure Route Influences Disease Severity in the COVID-19 Cynomolgus Macaque Model

Comparative pathogenesis of three Mayaro virus genotypes in the cynomolgus macaque

Longitudinal analysis of immunocyte responses and inflammatory cytokine profiles in SFTSV-infected rhesus macaques

Comparative pathogenesis of Ebola virus and Reston virus infection in humanized mice

Mayaro virus pathogenesis and immunity in rhesus macaques

Early Transcriptional Changes within Liver, Adrenal Gland, and Lymphoid Tissues Significantly Contribute to Ebola Virus Pathogenesis in Cynomolgus Macaques

Elucidating variations in the nucleotide sequence of Ebola virus associated with increasing pathogenicity

Transcriptional Analysis of Lymphoid Tissues from Infected Nonhuman Primates Reveals the Basis for Attenuation and Immunogenicity of an Ebola Virus Encoding a Mutant VP35 Protein

Monoclonal antibody therapy demonstrates increased virulence of a lineage VII strain of Lassa virus in nonhuman primates

Marburg and Ebola Virus Infections Elicit a Complex, Muted Inflammatory State in Bats

Development of a Well-Characterized Cynomolgus Macaque Model of Marburg Virus Disease for Support of Vaccine and Therapy Development

Natural history of Ebola virus disease in rhesus monkeys shows viral variant emergence dynamics and tissue-specific host responses

Asymptomatic Infection of Marburg Virus Reservoir Bats Is Explained by a Strategy of Immunoprotective Disease Tolerance

SARS-CoV-2 infection of African green monkeys results in mild respiratory disease discernible by PET/CT imaging and shedding of infectious virus from both respiratory and gastrointestinal tracts

Comparison of SARS-CoV-2 Infections Among Three Species of Non-Human Primates

Virulence differences of mpox (monkeypox) virus clades I, IIa, and IIb.1 in a small animal model

Pathogenic analysis of coxsackievirus A10 in rhesus macaques

Investigating the Cellular Transcriptomic Response Induced by the Makona Variant of Ebola Virus in Differentiated THP-1 Cells

Comparison of SARS-CoV-2 infections among 3 species of non-human primates

Isolation of Diverse Simian Arteriviruses Causing Hemorrhagic Disease